UTMD Financials
Utah Medical Products Inc - Financial statements & key metrics
Stock Price
$72.25
Market Cap
$189.83M
P/E Ratio
15.4
EPS
$3.96
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$9.16M
Gross Profit
-
Operating Income
-
Net Income
$2.90M
EPS (Diluted)
$0.86
Balance Sheet Highlights
Total Assets
$122.54M
Total Liabilities
$5.11M
Shareholders Equity
-
Cash & Equivalents
$82.98M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$14.83M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
31.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is UTMD revenue?
UTMD's most recent quarterly revenue was $9.16M. Annual revenue can be calculated by summing the four most recent quarters.
Is UTMD profitable?
UTMD reported a profit of $2.90M in the most recent quarter. The net profit margin is 31.7%.
What is UTMD market cap?
UTMD has a market capitalization of $189.83M, making it a small-cap stock.
Does UTMD have debt?
View UTMD's balance sheet for debt information.
What is UTMD cash flow?
Cash flow data is available in the full financial statements.